Skip to content
Trained Market Monkey
Contact
Monkey Business
Tag:
risk reward
Apr 14
When the Market Fears Gene Therapy (But Shouldn’t)
Apr 14
Charging Into the Future (Or Crashing Into Reality?)
Apr 14
When the Cure Costs Less Than the Stock: Inside Rocket Pharma’s Head-Scratching Approval Paradox
Apr 14
When the FDA Says Yes But the Stock Says Yikes: A Gene Therapy Paradox
Apr 14
When the FDA Says Yes But the Market Says Meh: Inside Rocket’s Paradox
Apr 14
When the FDA Says Yes But the Market Says Maybe: A Gene Therapy Gamble
Apr 14
When the FDA Says Yes But the Market Says Meh: A Monkey’s Guide to Rocket’s Peculiar Moment
Apr 14
When the FDA Gives You Lemons, Make Gene Therapy Lemonade
Apr 14
The Redmond Empire Strikes Back: Why Maurice Is Going All-In on the Cloud King
Apr 14
The Redmond Fruit Basket: Why Microsoft Might Be the Safest Bet in the Room Right Now
Next Page
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here:
Cookie Policy
Subscribe
Subscribed
Trained Market Monkey
Sign me up
Already have a WordPress.com account?
Log in now.
Trained Market Monkey
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
Trained Market Monkey 